Dr. Climer has received a 5-year grant from NIH to study the Alzheimer's disease, in collaboration with Washington University. The project will focus on designing and applying AI techniques to reveal novel traits and genetic variants, potentially leading to prospective therapeutic targets, and will also provide guidelines for accurate and practical assessments of the disease status, which will be invaluable for evaluations of effectiveness of experimental treatments in clinical trials.